A multicenter study of recombinant human erythropoietin (epoetin α) in the management of anemia in cancer patients receiving chemotherapy

Pawlicki, Marek; Jassem, Jacek; Bõsze, P; Lotan, Chana; P Kurteva, Galena; Siddiqui, Mohammed; Kosmidis, P.; Rigatos, Gerasimos; Kansu, Emin; Ďurkovič, P.; Aziz, Zeba; Idrissi, H.; Roth, Anton; Veniamin Cozma, Gabriel

doi:10.1097/00001813-199711000-00006

Public

A multicenter study of recombinant human erythropoietin (epoetin α) in the management of anemia in cancer patients receiving chemotherapy

Published in Anti-Cancer Drugs • Nov 1, 1997

Authors:

Marek Pawlicki

Jacek Jassem

P Bõsze

Abstract

Current evidence suggests that epoetin alpha administration is well tolerated and effective in the management of anemia of cancer and cancer chemotherapy. An open-label, multinational, non-comparative study was conducted in 215 cancer patients with anemia secondary to chemotherapy with platinum- or ...

Subject

Medicine

Epoetin alfa

Erythropoietin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!